Driving a 0-1 Sensor Connected Mobile App Initiative for People Living with Type-2 Diabetes.

Empowering Change

Opportunity Space

Role

Key Accomplishments

Process

Challenges

Outcome

Abbott Diabetes Care has long been at the forefront of diabetes management, particularly in monitoring Type-1 diabetes with the trusted FreeStyle continuous glucose monitors (CGM) for over a decade. Yet, addressing the needs of those with Type-2 diabetes posed a fresh and unique challenge. Unlike Type-1, Type-2 diabetes doesn't come with sudden symptoms or immediate consequences. Instead, managing Type-2 heavily relies on lifestyle choices.

Research showed that over 61% of individuals struggle with maintaining a healthy diet, while 58% found it challenging to stick to an exercise routine—both crucial for improved glucose management.

In response, I was tasked with identifying market potential, understanding the unique needs of this demographic, and leading the development of personalized, actionable lifestyle guidance. By leveraging Abbott's expertise and technology, I aimed to empower people living with Type-2 diabetes to make informed choices and achieve better health outcomes.

Senior Product Manager

Identify and define the opportunity, user base, strategy, and lead a cross-functional team and rally stakeholder and leadership support behind a 0-1 initiative as product lead.

Patent filing

Patent application for innovative digital tracking solution tailored to support individuals with Type-2 diabetes, emphasizing a CGM connected and intuitive design.

First closed and open betas

Launched the company's first closed/open beta research initiatives, using a sensor-connected mobile app to collect user feedback and drive truly agile improvements.

New design language

Introduced a new design language and system to gradually improve mobile user experience over time, addressing existing low mobile suite appstore ratings.

• Multiple segments with behavior change opportunities

• Medical sensor accessibility, affordability

• Integration of solution vs. standalone launch of solution

• Multiple competing internal/partnership initiatives

• Typical leadership and stakeholder buy-in and alignment

• Identified 2 new Type-2 Diabetes patient segments with market potential

• Identified a novel digital method for users to understand how lifestyle choices impact glucose in realtime

• Recruited over 40 participants in closed beta and tracked for over 100 for open beta.

• This solution invigorated several new efforts including external weight loss/lifestyle partnerships and other marketed approaches leveraging CGM sensors as biowearables.

• This app continues to be a innovative source of design language and iterative experimentation for new features prior to launch in production apps.